share offer, page-2

I've accepted the issue, however I don't have many shares...

Some exciting results coming next year from the African trial... very speculative at the moment as they have a low cash balance.

Possible income from the Transgene arrangement, but my money is on the African trial. Market could get very excited if this works well as it's a theraputic vaccine (DNDN for protate, Transgene successes etc)... shortish patent life, but possibe extensions on approval.

Basically it's a punt, are you feeling lucky?